See the DrugPatentWatch profile for lipitor

When combining Lipitor (atorvastatin) with SSRIs (selective serotonin reuptake inhibitors), it is important to consider potential interactions and effects on patient health. Lipitor is a commonly prescribed statin medication used to lower cholesterol levels, while SSRIs are a class of antidepressants. Research suggests that combining these medications may increase the risk of drug interactions and adverse effects. One study published in the National Center for Biotechnology Information (NCBI) highlighted the potential for drug-drug interactions between atorvastatin and certain SSRIs, leading to an increased risk of myopathy. Myopathy is a condition characterized by muscle pain or weakness, which can be a serious side effect. It is crucial for healthcare providers to monitor patients closely when using these medications together to minimize the risk of adverse effects and ensure patient safety [2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827898/
[3] https://pubmed.ncbi.nlm.nih.gov/24602259/